News Releases

2005

XXX
Dec.12,2005
Agreement on Joint Development and Marketing of Rivastigmine Transdermal Patch for the Treatment of Alzheimer's Disease (95.5KB)
XXX
Dec.06,2005
Ono Enters Into Joint Development/Co-Marketing Agreement on an Additional Indication for Cervical Spondylosis of Limaprost Alfadex, an Oral Prostaglandin E1 Derivative Preparation, with Dainippon Sumitomo (17.1KB)
XXX
Nov.04,2005
Ono Entered Into Drug Discovery Agreement on Kinases with Array BioPharma Inc. (63.2KB)
XXX
Oct.25,2005
Patient Enrollment for Phase III Clinical Studies with New HIV Drug (ONO-4128 / 873140) Terminated (101KB)
XXX
Sep.20,2005
Changes to the Development Program for ONO-4128 / 873140 (48.8KB)
XXX
Aug.10,2005
Development status of ONO-2506PO/Cereact® Capsules (69.6KB)
XXX
Jul.25,2005
Development Status Update of ONO-4128/873140 (7.9KB)
XXX
Jun.13,2005
Results of Phase II Studies of Sitagliptin (MK-0431 / ONO-5345) Investigational Treatment for Type 2 Diabetes Presented by Merck & Co., Inc. at ADA (33.4KB)
XXX
May.26,2005
Development Status of ONO-2506 for Injection/PROGLIA (9.3KB)
XXX
May.18,2005
Announcement concerning Changes of Representative Directors (49.9KB)
XXX
May.12,2005
Ono and Medarex Enter Into Collaborative Research Agreement on Antibody Product (53.2KB)
XXX
Apr.28,2005
Ono resolved increase in dividends projected for the fiscal year 2004(ending on March 31,2005) (146KB)
XXX
Apr.28,2005
Ono Pharmaceutical Announces Dissolution of a Subsidiary (16.9KB)
XXX
Mar.01,2005
New Data on New HIV Drug(Oral CCR5 Receptor Antagonist) (21.8KB)
XXX
Feb.28,2005
Development Status of ONO-2506 for Injection/PROGLIA outside Japan and Development Plan of Compounds in-licensed from Merck in Japan (97.5KB)
XXX
Jan.11,2005
Opening of a Contributed Chair at Kyoto University, Graduate School of Medicine and Faculty of Medicine (8.7KB)